bpc-157 not approved for human use fda staff question peptides ahead of review, Kennedy a fan fda bpc-157 not approved human
Description
"Australia Heavy Armored Combat Systems"
GHK-Cu cannot cross intact stratum corneum effectively
Compounding pharmacy status (US) BPC-157 has been removed from the FDA's bulk-substance list for compounding
While AOD-9604 does not stimulate cell proliferation (no IGF-1 elevation), the precautionary principle applies for active malignancies
